Aclarion publishes CEO letter on reimbursement progress and trial timeline

Go back to Aclarion publishes CEO letter on reimbursement progress and trial timeline
(NASDAQ: ACON) Delayed: 1.93 --0 (-0%)
Previous Close $1.93    52 Week High $ 
Open $1.88    52 Week Low $ 
Day High $1.97    P/E N/A 
Day Low $1.88    EPS $ 
Volume 10,315       

(NASDAQ: ACONW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High $ 
Open $0.03    52 Week Low $ 
Day High $0.03    P/E N/A 
Day Low $0.03    EPS $ 
Volume 430